Animal testing is the use of animals in scientific research. Such research is vital for patients with unmet medical needs.
EPF believes that properly regulated animal testing continues to be essential in many aspects of medical research and a vital and legally required stage in the development of treatments for patients.
Therefore, EPF supports animal based research for medicinal purposes undertaken in accordance with best practice in properly regulated research centres and where there is no alternative. We also support increased investment in seeking alternatives.
EPF and its members have endorsed a statement on the patients’ perspective on the use of animals in biomedical research.
Directive 2010/63/EU, governing animal research in Europe (revising Directive 86/609/EEC) was passed at its second reading in the European Parliament in September 2010. European patients groups were active in communicating the importance of the continuation of animal research to progress towards cures and treatments for currently unmet health needs, whilst also seeking viable alternatives to animal testing. Our combined voice brought a valuable balance to the debate.
The Directive is based on principles of “the 3Rs”: • Reduction of the number of animals used• Refinement of care and procedures • Replacement of animal testing by other methods where possible.
Member States will have to transpose it into their national legislation within two years.
Our member organisation, the European Genetic Alliance Network EGAN is leading work on developments at EU level on animal testing. For further information please contact:
Nick MeadePolicy AnalystGenetic Alliance UKUnit 4D, Leroy House436 Essex RoadLondon N1 3QPUnited KingdomT: +44 (0)20 7704 3141F: +44 (0)20 7359 1447
Page last modified: 4th February 2011
Statement on the patients’ perspective on the use of animals in biomedical research (October 2007)